13(S)-HOTrE
Based on 1 Customer Validation
13 (S)-HOTrE is an oxylipin metabolite of α-Linolenic acid (HY-N0728). 13 (S)-HOTrE mediates the inactivation of the NLRP3 inflammasome through the PPAR-γ pathway to exert anti-inflammatory effects. 13 (S)-HOTrE inhibits NF-κB nuclear translocation, ROS production, autophagy and IL-1β levels, induces apoptosis, and increases IL-10 levels. 13 (S)-HOTrE alleviates LPS-induced inflammatory responses in macrophages, prolongs the survival time of septic mice, and regulates the immunometabolic phenotype in parenteral nutrition mouse models. 13 (S)-HOTrE can be used in the research of immune and inflammation-related diseases.
For research use only. We do not sell to patients.
- Purity : 99.9%
- CAS No.: 87984-82-5
- Formula: C18H30O3
- Molecular Weight:294.43
-
Storage:
Solution, -20°C, 2 years
All Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
NF-κB |
PPAR-γ |
IL-1β |
IL-10 |
NLRP3 |
iNOS |
Caspase-1 |
TNF-α |
In Vitro
13(S)-HOTrE (1-200 μM; 24 h) exhibits dose-dependent cytotoxicity against RAW 264.7 cells, with an IC50 > 200 μM at 24 h[1].
13(S)-HOTrE (1-100 μM; 3 h pre-incubation; 24 h LPS stimulation) reduces LPS-induced NO production in RAW 264.7 cells; inhibits the protein expression of iNOS, TNF-α and COX-2 in a dose-dependent manner; and decreases the transcriptional levels of NLRP3, caspase-1, IL-1β and IL-18 as well as IL-1β secretion in a dose-dependent manner[1].
13(S)-HOTrE (100 μM; 3 h pre-incubation; 16 h LPS stimulation) inhibits LPS-induced NF-κB nuclear translocation in RAW 264.7 cells at a pre-treatment dose of 100 μM[1].
13(S)-HOTrE (1-100 μM; 3 h pre-incubation; 16 h LPS stimulation) reduces LPS-induced ROS production in RAW 264.7 cells in a dose-dependent manner, with an inhibition rate of 92.7% under the pre-treatment condition of 100 μM[1].
13(S)-HOTrE (100 μM; 3 h pre-incubation; 24 h LPS stimulation) inactivates LPS-induced NLRP3 inflammasome and reduces caspase-1 expression in RAW 264.7 cells at a pre-treatment dose of 100 μM via a PPAR-γ-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:RAW 264.7 mouse macrophage cells
-
Concentration:1, 10, 100, 200 μM
-
Incubation Time:24 h
-
Result:Reduced RAW 264.7 cell proliferation in a dose-dependent manner, with less cytotoxicity than 13(S)-HPOTrE.
Had an IC50 for reduction of cell proliferation greater than 200 μM at 24 hours.
-
Cell Line:LPS-stimulated RAW 264.7 mouse macrophage cells
-
Concentration:1, 5, 100 μM
-
Incubation Time:3 h pre-incubation; 24 h LPS stimulation
-
Result:Reduced LPS-induced iNOS and TNF-α protein expression in a dose-dependent manner. Enhanced LPS-induced COX-2 protein expression in a dose-dependent manner.
-
Cell Line:LPS-stimulated RAW 264.7 mouse macrophage cells
-
Concentration:100 μM
-
Incubation Time:3 h pre-incubation; 16 h LPS stimulation
-
Result:Reduced LPS-induced NF-κB translocation to the nucleus.
-
Cell Line:LPS-stimulated RAW 264.7 mouse macrophage cells
-
Concentration:1, 50, 100 μM
-
Incubation Time:3 h pre-incubation; 24 h LPS stimulation
-
Result:Reduced LPS-induced NLRP3, caspase-1, IL-1β, and IL-18 transcript levels in a dose-dependent manner.
-
Cell Line:LPS-stimulated RAW 264.7 mouse macrophage cells
-
Concentration:1, 50, 100 μM
-
Incubation Time:3 h pre-incubation; 24 h LPS stimulation
-
Result:Reduced LPS-induced IL-1β levels by 23% in a dose-dependent manner at 100 μM pre-treatment.
-
Cell Line:LPS-stimulated RAW 264.7 mouse macrophage cells
-
Concentration:100 μM
-
Incubation Time:3 h pre-incubation; 24 h LPS stimulation
-
Result:Inactivated the NLRP3 inflammasome and downregulated caspase-1 expression; this effect was reversed by co-incubation with 10 μM GW9662 (HY-16578), a PPAR-γ antagonist.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c (male, 4-week old, 20-25 g, endotoxin-mediated septic shock model via intraperitoneal LPS injection)[1]
-
Dosage:0.1 mg/kg
-
Administration:i.p.; two doses (1 hour prior to LPS injection, immediately after LPS injection)
-
Result:Increased survival rate by 10% compared to LPS-only treated mice.
-
Animal Model:BALB/c (male, 20-25 g, polymicrobial sepsis model via cecal ligation and puncture surgery)[1]
-
Dosage:0.1 mg/kg
-
Administration:i.p.; two doses (1 hour prior to CLP surgery, immediately after CLP surgery)
-
Result:Reduced iNOS and NLRP3 protein expression in mouse tissue.
Decreased pro-inflammatory IL-1β levels in serum and liver tissue.
Increased anti-inflammatory IL-10 levels in serum, compared to CLP-only mice.
Chemical Information
-
CAS No. 87984-82-5
-
Appearance Liquid
-
Molecular Weight 294.43
-
Formula C18H30O3
-
SMILES
OC(CCCCCCC/C=C\C=C\[C@@H](O)C/C=C\CC)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Solution, -20°C, 2 years
Protocols
-
Cytoplasmic-Nuclear Fractionated Protein Extraction
Cytoplasmic-nuclear fractionated protein extraction separates soluble cytoplasmic proteins from nuclear-enriched proteins by mild plasma-membrane permeabilization, differential centrifugation, washing of nuclei, and extraction of nuclear proteins for downstream immunoblotting or related molecular analysis. The readout is the relative abundance of a protein in cytoplasmic and nuclear fractions, commonly assessed by western blotting together with compartment markers such as tubulin or pyruvate kinase for cytoplasm and lamin, nucleoporin, hnRNP, H2AX, or Lamin B for nuclear fractions.
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
Pyroptosis Solutions
Pyroptosis is a lytic inflammatory cell-death pathway executed by gasdermin pores, most classically through inflammasome-mediated activation of caspase-1, cleavage of gasdermin D, membrane pore formation, LDH release, and secretion of IL-1β and IL-18. The canonical pathway is commonly modeled by priming cells with an inflammatory signal such as LPS to induce pro-IL-1β and inflammasome components, followed by an activation signal such as ATP or nigericin to activate NLRP3, ASC speck formation, caspase-1 cleavage, GSDMD cleavage, cytokine release, and pyroptotic membrane rupture. The non-canonical pathway is triggered when cytosolic LPS activates mouse caspase-11 or human caspase-4/5, leading to GSDMD cleavage and pyroptosis, and this can secondarily activate NLRP3-dependent IL-1β release. Pyroptosis is linked to inflammatory injury, infection, cancer, liver disease, ocular disease, placental inflammation, and other disease phenotypes, but unresolved questions include which gasdermin fam
Purity & Documentation
-
Data Sheet (274 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Korean - KR (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Kumar N, et al. 15-Lipoxygenase metabolites of α-linolenic acid, [13-(S)-HPOTrE and 13-(S)-HOTrE], mediate anti-inflammatory effects by inactivating NLRP3 inflammasome. Scientific reports. 2016 Aug 18;6:31649. [Content Brief]
[2]. Cambiaggi L, et al. The Role of α-Linolenic Acid and Its Oxylipins in Human Cardiovascular Diseases. International journal of molecular sciences. 2023 Mar 24;24(7):6110. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)